News Feed
Soligenix to Present at BIO CEO & Investor Conference
PRINCETON, N.J., Feb. 4, 2025 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today […]